CrossBridge Bio’s innovative approach to create stable, multi-loaded antibody–drug conjugates is set to generate a suite of first-in-class and best-in-class cancer therapies. Antibody–drug ...

Teams do not pay a fee for placement on Forbes Top Advisor rankings, which are independently determined by Shook Research. Source: Forbes.com (Awarded Jan 2025) Data Compiled By Shook Research LLC ...